Orange, California Clinical Trials
A listing of Orange, California clinical trials actively recruiting patient volunteers.
Found 22 clinical trials
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.
- 0 views
- 13 May, 2025
- 1 location
- Online study
A THREE-MONTH CLINICAL STUDY TO ASSESS PARTICIPANT EXPERIENCE, WELLNESS, PHYSIOLOGICAL AND BLOOD BIOMARKERS FOLLOWING DAILY NUTRAMETA™ ADMINISTRATION WITH A THREE-MONTH EXTENSION
This study is evaluating an over-the-counter supplement for weight loss that uses a combination of natural ingredients that have been safely used by humans for hundreds of years. Our research suggests that a unique combination of those ingredients can have a metabolic and neurological benefit if taken over time.
- 0 views
- 03 Sep, 2024
- 1 location
- Online study
The 23andMe Lung Cancer Genetic Study
the lung cancer community and scientists want to learn more about the genetics of people diagnosed with lung cancer and help improve care in the future. While research and targeted therapies have provided hope and progress for many, we still don't know much about the disease and its causes. Your …
- 0 views
- 09 Jan, 2025
- 1 location
- Online study
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Trial) and to determine whether treatment with lecanemab is superior to placebo in reducing brain …
- 0 views
- 10 Jan, 2025
- +105 other locations
- 0 views
- 17 Mar, 2025
- +28 other locations
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Participants will either …
- 0 views
- 23 Dec, 2024
- +6 other locations
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
This trial will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors that meet protocol-specified biomarker criteria
- 0 views
- 10 Jan, 2025
- +25 other locations
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
This is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and Japan. Patients will be enrolled in the study after the introduction of efanesoctocog alfa in …
- 0 views
- 03 Dec, 2024
- +5 other locations
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
This is a Phase 2, international, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, 12-week study. It is designed to assess the therapeutic dose, efficacy, and safety of treatment with SAR441566 in male and female adults with moderate to severe plaque psoriasis. Study details include a screening period (4 weeks and not less …
- 0 views
- 28 Jun, 2024
- +56 other locations
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids
This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe atopic dermatitis (AD) with a history of inadequate response of topical treatment, on background topical corticosteroid (TCS) and/or topical calcineurin inhibitor (TCI). The purpose of this study is …
- 0 views
- 03 Dec, 2024
- +86 other locations